What should I know about Elaprase before receiving it?


Elaprase is used to treat Hunter's syndrome. While it improves the physical ability of people with Hunter's syndrome, it does not cure the disease.

While receiving the medicine through intravenous (IV) infusion, some people may experience dizziness, lightheadedness, hives, seizures, difficulty breathing, or swelling of the face, lips, tongue, or throat due to an allergic reaction to the drug. Sometimes these reactions are life-threatening, so people should be watched closely for up to 24 hours after receiving the drug. People who experience mild reaction symptoms can still receive subsequent infusions of Elaprase with additional pre-treatment. Lung diseases such as asthma may increase the risk of reactions to Elaprase.

People receiving Elaprase may need to be listed on a registry to track the progression of their disease and the effects of their treatment.

Continue Learning about Endocrine-Metabolic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.